Target intelligence / Profile preview

Cyclin B1 interacting protein 1 pseudogene 3 (CCNB1IP1P3)

Target
CCNB1IP1P3
Molecular classification
Other (Pseudogene)
01

Overview

Cyclin B1 interacting protein 1 pseudogene 3 (CCNB1IP1P3) is **classified as a pseudogene**, meaning it is a genomic DNA sequence similar to a functional gene (Cyclin B1 interacting protein 1, CCNB1IP1) but is **incapable of producing a functional protein product** due to disabling mutations or transcriptional inactivity[1][2][4]. Pseudogenes may retain some sequence similarity to their functional parent genes, but they do not typically code for proteins, are not considered therapeutic targets, and have no validated pharmacological or clinical importance. There is no evidence for biological function, disease relevance, or drug interactions for CCNB1IP1P3. Its annotation and nomenclature follow HGNC guidelines for pseudogenes, with a "P" followed by a number to indicate its pseudogene status and relationship to the parent gene CCNB1IP1[4]. **Note:** The biologically relevant protein is **Cyclin B1 interacting protein 1 (CCNB1IP1, also known as CIP1)**, not CCNB1IP1P3[5]. CCNB1IP1 is a ubiquitin E3 ligase involved in meiosis and cell cycle regulation, and does have functional roles and possible disease associations[5]. However, **CCNB1IP1P3 is a nonfunctional pseudogene** and not a validated drug target, receptor, or enzyme[1][4].

Other names
Cyclin B1 Interacting Protein 1 Pseudogene 3CCNB1IP1P3
02

Mechanism of action

None

03

Biological functions

None (pseudogene; not known to encode a protein or function in canonical signaling or enzymatic roles)
04

Disease associations

None known (no validated disease associations due to lack of protein function)

Beyond the preview

Go deeper on Cyclin B1 interacting protein 1 pseudogene 3 (CCNB1IP1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin B1 interacting protein 1 pseudogene 3 (CCNB1IP1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call